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1. Introduction
Bacterial magnetosomes are specialized intracellular organelles, 
which are synthesized by magnetotactic bacteria for orientation 
along geomagnetic field lines. In the alphaproteobacterium Mag-
netospirillum gryphiswaldense and related bacteria they consist of 
an inorganic, monocrystalline core of magnetite (Fe3O4), envel-
oped by a biological membrane that contains phospholipids and 
a set of magnetosome specific proteins. The latter fulfill various 
functions in and exert strict biological control over magnetosome 
biosynthesis.[1–5] In addition, biomineralized crystals exhibit 
characteristics superior compared to those of abiogenic (i.e., 
inorganic, chemically synthesized) nanoparticles. Under optimal, 
low-oxygen conditions, magnetotactic bacteria synthesize mag-
netosomes that possess a narrow size distribution and uniform 
morphology. Usually, the particles are large single magnetic 
domain nanoparticles with a strong magnetization and a stable 
Their unique material characteristics, i.e. high crystallinity, strong magnetization, 
uniform shape and size, and the ability to engineer the enveloping membrane 
in vivo make bacterial magnetosomes highly interesting for many biomedical 
and biotechnological applications. In this study, a versatile toolkit is developed 
for the multifunctionalization of magnetic nanoparticles in the magnetotactic 
bacterium Magnetospirillum gryphiswaldense, and the use of several abundant 
magnetosome membrane proteins as anchors for functional moieties is explored. 
High-level magnetosome display of cargo proteins enables the generation of engi-
neered nanoparticles with several genetically encoded functionalities, including a 
core–shell structure, magnetization, two different catalytic activities, fluorescence 
and the presence of a versatile connector that allows the incorporation into a 
hydrogel-based matrix by specific coupling reactions. The resulting reusable 
magnetic composite demonstrates the high potential of synthetic biology for the 
production of multifunctional nanomaterials, turning the magnetosome surface 
into a platform for specific versatile display of functional moieties.
magnetic moment at physiological temper-
atures. The magnetite core itself is of high 
purity and crystallinity, being protected 
against oxidation processes by the sur-
rounding magnetosome membrane.[6–11] 
These features and their natural biocom-
patibility make magnetosomes a promising 
tool for numerous biotechnological and 
biomedical applications, such as nano-
carriers in magnetic drug targeting, magne-
tosome-based immunoassays, as reporters 
for magnetic resonance imaging (MRI) or 
for magnetic hyperthermia.[3,12–14]
Many of these applications require fur-
ther functionalities, resulting in a strong 
need for a tunable, specific magnetosome 
display system that allows the simulta-
neous and selective addition of several 
functional moieties to the particle surface. 
Chemical coupling has been used to func-
tionalize magnetosomes in vitro,[15,16] but 
often lacks selectivity and requires harsh denaturing conditions, 
which might abolish biological activity. In contrast, the mag-
netosome membrane can be manipulated in vivo by genetic 
means. Foreign functional moieties can be expressed as trans-
lational fusions to magnetosome membrane (Mam) proteins, 
thereby specifically targeting these cargo proteins to the magne-
tosome envelop. Mam proteins with non-essential and redun-
dant functions like the highly abundant MamC have already 
been used as anchors for the display of fluorophores, camelid 
antibody fragments (nanobodies), and a variety of receptors 
and enzymes.[17–23] Previous studies demonstrated that magne-
tosome expression of cargo proteins can be increased by engi-
neering the transcription and translation of genetic fusions. An 
improved magnetosome expression cassette was developed by 
optimizing the strong, native PmamDC promoter and the ribo-
some binding site (RBS) of the mamGFDC operon.[18] Expres-
sion of codon-optimized egfp (= megfp) as translational fusion to 
mamC resulted in 2.8-fold increased fluorescence (compared to 
the non-optimized system). Another reporter for magnetosome 
expression of gene fusions is provided by the well-characterized 
enzyme glucuronidase GusA from Escherichia coli. Using the 
improved expression cassette, multifunctional magnetosomes 
were generated by expression of mixed arrays of up to five 
copies of GusA and an additional terminal mEGFP (as transla-
tional reporter) as large single hybrid proteins on the magneto-
some surface using MamC as membrane anchor.[23] This study 
also demonstrated that multimeric enzymes can be efficiently 
displayed on magnetosomes in high copy numbers, thereby 
covering up to 90% of the particle surface and triplicating the 
specific enzymatic activity per magnetosome.
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. This is an open access article under the terms of the Creative 
Commons Attribution License, which permits use, distribution and repro-
duction in any medium, provided the original work is properly cited.
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However, the number of MamC mem-
brane anchors is limited to 80–250 copies 
per particle,[18,23,24] and simultaneous multi-
functionalization by various different ligands 
requires the exploration of alternative mag-
netosome membrane proteins as potential 
expression anchors. For example, the integral 
membrane proteins MamG, MamF as well as 
the membrane-associated MamA were iden-
tified as highly abundant, surface-exposed 
Mam proteins. Because of their non-essen-
tial functions in magnetosome biosynthesis, 
fusions to them are not likely to interfere with 
magnetite biomineralization.[24–26] Their spe-
cific cellular association with magnetosomes 
was already demonstrated by the use of GFP 
fusions to MamA, MamG, and MamF.[17,24] 
The latter was furthermore used as single 
anchor protein for magnetosome display of 
protein A, thereby generating magnetic beads 
that were capable of binding the FC region 
of mammalian antibodies.[27,28] However, it 
so far remained unexplored if these Mam 
proteins can be utilized for simultaneous 
magnetosome expression of more complex, 
multimeric (enzyme) proteins.
In this study, we explored MamA, MamG 
and MamF for their use as potential magne-
tosome anchor proteins using mEGFP and 
GusA as reporters. Enzymatic activities and 
the amount of GusA correlated well with the 
estimated abundances of the respective membrane anchors 
(including MamC). These techniques were subsequently com-
bined into a versatile toolkit for the highly selective magneto-
some multifunctionalization. The potential of this approach was 
demonstrated by engineering bioconjugated magnetic nanopar-
ticles that simultaneously display the enzyme proteins GusA and 
glucose oxidase (GOx), a fluorophore (mEGFP) and a nanobody 
(red fluorescent binding protein, RBP) on the surface. Thereby, 
we generated a reusable magnetic model composite, in which all 
displayed functionalities were fully genetically encoded and can 
be easily substituted by any other desired protein-based func-
tional moieties. Thus, our synthetic biology approach can be 
effectively used for the generation of biohybrid nanomaterials, 
which have great potential for many applications in the biotech-
nological and biomedical field.
2. Results and Discussion
2.1. MamA, MamF, and MamG Proteins Can Be Used as Fusion 
Anchors for High-Level Magnetosome Display of Functional 
Cargo Proteins
To assess the abundances and suitability of MamA, MamF and 
MamG as magnetosome anchors, GusA-mEGFP reporter con-
structs arranged as dual tandem arrays were expressed indi-
vidually as C-terminal genetic fusions to the respective Mam 
proteins (Figure 1). Each construct was placed behind the 
strong constitutive magnetosomal PmamDC45 promotor with an 
optimized ribosome binding site (oRBS)[18] and transferred into 
the wildtype strain of M. gryphiswaldense and the respective dele-
tion mutants (∆mamA, ∆mamF or ∆mamG) via conjugative Tn5 
transposition.[29] The resulting chromosomal insertion strains 
WT::mamA-gusA-megfp, WT::mamF-gusA-megfp, WT::mamG-
gusA-megfp, ∆mamA::mamA-gusA-megfp, ∆mamF::mamF-gusA-
megfp, and ∆mamG::mamG-gusA-megfp were undistinguishable 
from the wildtype with regard to growth, morphology and 
magnetosome biosynthesis. Cells of all strains displayed fluo-
rescence signals localized ad midcell, reflecting the typical 
position of the magnetosome chain (Figure 2A, Figure S1, 
Supporting Information). As expected, fluorescence intensities 
were lower compared to strains in which mEGFP was fused 
to the highly abundant MamC protein present in about 85 
copies per particle (WT::mamC-gusA-megfp and ∆mamC::mamC-
gusA-megfp),[23] and followed the known relative abundances 
of the respective membrane anchors (MamC > MamA > 
MamF > MamG) (Figure 2B).[24,26] In the deletion strains 
∆mamC/A/F/G lacking the respective single wildtype alleles, 
signal intensities were nearly twice as high as for the corre-
sponding complemented wildtype strains in which additional, 
unfused wildtype copies of the Mam anchors were still present. 
Assuming a roughly linear correlation between fluorescence 
and mEGFP copy number (as shown by Lang and Schüler[17]) 
74, 62, or 56 mEGFP moieties per particles were calculated 
for strains ∆mamA::mamA-gusA-megfp, ∆mamF::mamF-gusA-
megfp, and ∆mamG::mamG-gusA-megfp, respectively (Table S1, 
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Figure 1. Schematic representation showing A) the genetic organization of the gusA-megfp 
expression cassettes and B) the topology of the resulting fusion proteins. The β-glucuronidase 
GusA and mEGFP were expressed as genetic fusions to MamF/G/A via G10 linkers composed of 
ten glycine residues (size of particles and proteins not to scale). Structure models of MamF/G/A 
according to predictions by Nudelman and Zarivach.[33]
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Supporting Information). Electrophoretic mobility of proteins 
solubilized from isolated magnetosomes were as predicted for 
the Mam-GusA-mEGFP fusion proteins (Figure 3A, Table S2, 
Supporting Information) indicating proper and stable expres-
sion. From band intensities in quantitative Western blots 
(Table S1, Supporting Information; Figure 3B) GusA amounts 
of 102, 74, and 69 ng GusA per µg Fe were calculated for 
strains ∆mamA::mamA-gusA-megfp, ∆mamF::mamF-gusA-megfp, 
and ∆mamG::mamG-gusA-megfp, respectively, which is in good 
agreement with the estimated mEGFP copy numbers as cal-
culated from fluorescence microscopy. Thus, the amount of 
the respective membrane anchors and cargo proteins could be 
estimated to be ≈85 (MamA), ≈66 (MamF), and ≈60 (MamG) 
copies per particle (Table S1, Supporting Information).
All GusA-mEGFP magnetosome species displayed glu-
curonide-hydrolyzing activities (Figure 3; Figure S2 and 
Table S2, Supporting Information). Calculated reaction rates, 
which served as an indicator for the amount of catalytically 
active enzyme, again correlated with the GusA protein con-
tent of the particles and thus, with the relative abundances of 
the utilized anchor proteins. Specific activities were between 
11.4 and 20.5 U mg−1 GusA (Table S2, Supporting Informa-
tion), thus in most cases significantly higher compared to 
soluble GusA expressed in M. gryphiswaldense (12.7 U mg−1 
GusA).[23] Specific activities per mg Fe were between 0.46 
U mg−1 Fe (WT::mamG-gusA-megfp) and 1.52 U mg−1 Fe 
(∆mamF::mamF-gusA-megfp), which reflected 
the amount of enzyme present on the par-
ticle surface. The different GusA fusions 
exhibited relatively low Michaelis-Menten 
(KM) constants (0.12 × 10−3 to 0.23 × 10−3 m) 
indicating high affinities for the substrate 
p-nitrophenyl-β-D-glucuronide.[30,31] Since 
GusA is known to function only as a 272 kDa 
homotetramer,[32] the high activities indicate 
proper folding and assembly of GusA mono-
mers into tetrameric structures, which appar-
ently was not impaired by the fusions at both 
termini to the magnetosome anchors and 
mEGFP, respectively.
In contrast to MamF, MamG and MamC 
proteins, which are integral and tightly bound 
to the magnetosome membrane, MamA is 
only associated with the magnetosome sur-
face and can be solubilized by mild detergents 
and high ionic strength.[26,33,34] However, only 
insignificant amounts (1.3% of the total GusA 
content and 1.4% glucuronide-hydrolyzing 
activity) of MamA-GusA-mEGFP from strain 
WT::mamA-gusA-megfp were lost during mag-
netosome isolation (Figure S3, Supporting 
Information), as shown by quantitative 
Western blots and enzymatic analysis of the 
non-magnetic fraction (i.e., the magnetosome-
free flow-through). This indicated a sufficiently 
stable association with the magnetosome 
membrane of MamA as an anchor protein.
2.2. Generation of Multifunctional Magnetic Nanoparticles  
by Simultaneous Display of Various Cargo Proteins
So far, our results had demonstrated that in addition to the 
highly abundant MamC, the magnetosome proteins MamF, 
MamG and MamA are suitable anchors for stable display of 
individual cargo proteins, if also present in somewhat lower 
numbers per particle. Next, we explored whether these Mam 
proteins can be combined for simultaneous magnetosome 
display of diverse functional moieties. For that purpose, we 
designed a model particle that in addition to magnetization 
should display four additional genetically encoded function-
alities: i) two different enzymatic activities (GusA and GOx), 
ii) the ability of versatile coupling (by expression of a nano-
body), and iii) mEGFP fluorescence (Figure 4A). The latter was 
introduced by replacing the native mamA by a mamA-megfp 
fusion in the wildtype and ∆mamGFDC strain of M. gryph-
iswaldense (in-frame replacement by a markerless mutagenesis 
approach[35]), resulting in strains ∆mamA::mamA-megfp and 
∆mamGFDC_∆mamA::mamA-megfp, respectively. Next, a com-
pact expression cassette was designed that allowed the simul-
taneous display of MamC fused to a RBP nanobody directed 
against its cognate antigen Red Fluorescent Protein (mCherry) 
as a connector, MamF fused to the glucuronidase GusA, and 
MamG fused to GOx (Figure 4A). GOx was chosen for magne-
tosome expression because it represents a more complex, i.e. 
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Figure 2. A) TEM microscopy images of representative WT::mamA-gusA-megfp and 
∆mamA::mamA-gusA-megfp cells indicated a wildtype (WT)-like phenotype with one or two 
magnetosome chains positioned at midcell. megfp expression was confirmed by fluorescence 
microscopy (insets), showing fluorescence signals at magnetosome chain position (for mamF/
G-gusA-megfp expressing strains refer to Figure S1, Supporting Information). B) Cellular mEGFP 
fluorescence from various gusA-megfp fusions of M. gryphiswaldense. Fluorescence was nor-
malized to cell density and reported as relative fluorescence units (RFU). Error bars represent 
standard deviations, calculated from at least three independent measurements. Signal intensi-
ties indicate a clear correlation with the known abundances of the utilized membrane anchors 
(estimated by Raschdorf et al.[24] and Grünberg et al.[26]). Values for WT::mamC-gusA-megfp and 
∆mamC::mamC-gusA-megfp taken from Mickoleit and Schüler.[23]
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dimeric and cofactor-dependent, enzyme with biotechnological 
relevance.[36] It catalyzes the oxidation of glucose yielding glu-
cono-lactone that is subsequently hydrolyzed to gluconic acid 
and H2O2. Its glycosylation in the native host Aspergillus niger 
was shown to be dispensable for catalytic activity.[37] While 
chemical coupling of purified GOx to isolated magnetosomes 
was reported before,[38] we attempted to genetically express 
monomeric GOx as translational fusion to MamG in vivo. For 
that purpose, the corresponding sequence 
from A. niger was back-translated and codon-
optimized for M. gryphiswaldense. Within the 
PmamDC45_mamG-gox_mamF-gusA_mamC-rbp  
expression cassette generated by Gibson 
Assembly (Figure S4, Supporting Informa-
tion), mamG/F/C fusions were arranged 
according to their genetic organization in the 
mamGFDC operon. The ∆mamA::mamA-megfp 
and ∆mamGFDC_∆mamA::mamA-megfp strain 
of M. gryphiswaldense were chosen as recipi-
ents for the mamG-gox/mamF-gusA/mamC-rbp 
gene fusions. Upon chromosomal insertion, 
the resulting strains ∆mamA::mamA-megfp_
mamG-gox_mamF-gusA_mamC-rbp and 
∆mamGFDC_∆mamA::mamA-megfp_mamG-
gox_mamF-gusA_mamC-rbp showed slower 
growth (doubling time of 10.4 h for the 
∆mamA background and 11.9 h for the 
∆mamGFDC_∆mamA background, com-
pared to 6.9 and 7.5 h for untransformed 
parental strains, respectively). These obser-
vations might be explained by the GOx 
activity, which in the presence of intracel-
lular glucose produces toxic H2O2 that 
might not be fully counteracted by cellular 
catalase. Despite of this growth impairment, 
cell morphology, magnetosome arrange-
ment and particle yields in mamA-megfp_
mamG-gox_mamF-gusA_mamC-rbp strains 
were undistinguishable from the wildtype 
(∆mamA::mamA-megfp_mamG-gox_mamF-
gusA_mamC-rbp: 26 ± 9 particles per cell,  ∅ 
34 ± 8 nm; ∆mamGFDC_∆mamA::mamA-
megfp_mamG-gox_mamF-gusA_mamC-rbp: 
26 ± 9 particles per cell, ∅ 31 ± 9 nm; 
Figure S5, Supporting Information). The four 
MamGFDC proteins have overlapping and 
partially redundant functions and act in a 
cooperative manner on the crystal size, with 
three of the four Mam proteins being suf-
ficient to complement the ∆mamGFDC phe-
notype (i.e., reduced particle sizes).[25] Thus, 
our data indicate the successful comple-
mentation of the ∆mamGFDC mutation by 
restoration of the wildtype phenotype.
Each subunit of GOx requires one mole-
cule of flavin adenine dinucleotide (FAD) 
and chelated iron to be functional,[36] which 
needs to be contributed by the endogenous 
cellular pool of the GOx-expressing host 
M. gryphiswaldense. Only small amounts of FAD were deter-
mined in the solubilized and denatured magnetosome mem-
brane fraction of untransformed wildtype and ∆mamGFDC 
strains (most probably due to unspecific binding to the 
membrane). In contrast, for magnetosomes of strains 
∆mamA::mamA-megfp_mamG-gox_mamF-gusA_mamC-rbp 
and ∆mamGFDC_∆mamA::mamA-megfp_mamG-gox_mamF-
gusA_mamC-rbp an FAD content of 19 or 32.6 µmol per g Fe 
Small 2020, 16, 1906922
Figure 3. Magnetosome expression of MamC/A/F/G-GusA-mEGFP fusion proteins. The WT of 
M. gryphiswaldense and the deletion mutants ∆mamC/A/F/G were complemented with the indi-
cated mam-gusA-megfp fusions. A) Microoxically grown cells were harvested and disrupted, and 
the solubilized membrane fractions of isolated magnetosomes (12 or 24 µg Fe per lane) were 
subjected to denaturing PAGE followed by quantitative Western blotting employing an IgG anti-
body directed against GusA. Electrophoretic mobility of the detected bands corresponded well 
to the calculated molecular masses of the fusion proteins. Degradation products potentially 
caused in the course of sample preparation were detected to only minor extents. Commercial, 
soluble GusA (cs) served as control. B) Bar chart illustrating the correlation between GusA 
amounts displayed on the magnetosome surface (calculated from quantitative Western blots) 
and GusA reaction rates (vmax; calculated from kinetic measurements as the mean of Michaelis-
Menten, Lineweaver-Burk, and Hanes-Woolf plots, Figure S2, Supporting Information). GusA 
protein amounts and vmax values were consistent with the known abundances of MamC/A/F/G 
in the magnetosome membrane. Values for WT::mamC-gusA-megfp and ∆mamC::mamC-gusA-
megfp taken from Mickoleit and Schüler.[23]
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was measured, roughly corresponding to 0.08 U of commer-
cial, soluble GOx (Table S3, Supporting Information). GOx 
enzymatic activities are usually determined by peroxidase-
based assays. However, the latter were compromised, prob-
ably by the presence of that redox-active magnetite core (data 
not shown).[39] Therefore, an alternative assays was adopted to 
quantify electron transfer reactions.[40] For magnetosomes of 
both strains (∆mamA::mamA-megfp_mamG-gox_mamF-gusA_
mamC-rbp and ∆mamGFDC_∆mamA::mamA-megfp_mamG- 
gox_mamF-gusA_mamC-rbp, each 2.5 µg Fe) time-dependent 
absorption increases were monitored (Figure 4B), indicating 
glucose oxidizing activity. For wildtype magnetosomes (nega-
tive control) only low, insignificant background activities were 
detected. Since the GOx enzyme is likely to be functional as 
a dimer, monomers from adjacent MamG-GOx fusions might 
together contribute to the formation of such dimers.[41,42]
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Figure 4. Generation of multifunctional model particles by utilization of four different Mam proteins as membrane anchors. A) Simultaneous expres-
sion of four different gene fusions (mamA-megfp, mamG-gox, mamF-gusA, and mamC-rbp) in the ∆mamA or ∆mamGFDC_∆mamA background 
allowed the surface display of mEGFP, glucose oxidase (GOx), the glucuronidase GusA, and the red fluorescent protein-binding nanobody (RBP) as 
versatile “connector” for coupling reactions to any RFP/mCherry-tagged structures. Size of particles and proteins not to scale. B) Isolated particles 
from strains ∆mamA::mamA-megfp_mamG-gox_mamF-gusA_mamC-rbp or ∆mamGFDC_∆mamA::mamA-megfp_mamG-gox_mamF-gusA_mamC-rbp 
were subjected to GOx activity assays employing MPMS as intermediate electron “carrier” for the reduction of INT to yield formazan (Figure S5, 
Supporting Information). Compared to wildtype magnetosomes, linear absorption increases were monitored, indicating glucose-oxidizing activity. 
C) Incubation of isolated MamA-mEGFP_MamG-GOx_MamF-GusA_MamC-RBP particles with the artificial substrate X-Gluc resulted in the for-
mation of 5,5′-dibromo-4,4′-dichloro-indigo and thus, a characteristic blue color, thereby confirming GusA activity. D) DIC (left) and fluorescence 
microscopy images (middle and right) of MamA-mEGFP_MamG-GOx_MamF-GusA_MamC-RBP magnetosomes. Expression of mEGFP was veri-
fied by distinct fluorescence signals suggesting the formation of small magnetosome aggregates (middle). Display of functional RBP moieties was 
confirmed by incubating isolated particles with commercial, soluble mCherry (right). Unbound/excess protein was removed by magnetic separation 
and extensive washing. Fluorescence signals at identical positions as for mEGFP indicated successful binding of the fluorophore to the magneto-
some surface.
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MamA-mEGFP_MamG-GOx_MamF-GusA_MamC-RBP 
magnetosomes exhibited glucuronide-hydrolyzing activity 
as indicated by the conversion of the artificial substrate 
5-Bromo-4-chloro-3-indolyl-β-D-glucuronide (X-Gluc) into a 
blue solution (Figure 4C). Furthermore, quantitative Western 
blotting was used to specifically detect GusA and mEGFP in the 
solubilized magnetosome membrane fraction (Figure S6, Sup-
porting Information). For both strains distinct bands of ≈85 kDa 
or ≈50 kDa were detected, respectively, corresponding well to 
the predicted molecular masses of 81.4 kDa (MamF-GusA) and 
51.7 kDa (MamA-mEGFP). The amount of GusA was quanti-
fied to be 55.1 ng (∆mamA::mamA-megfp_mamG-gox_mamF-
gusA_mamC-rbp) or 62.4 ng (∆mamGFDC_∆mamA::mamA-
megfp_mamG-gox_mamF-gusA_mamC-rbp), which is in accord-
ance with values obtained before for MamF-GusA-mEGFP 
magnetosomes (Table S2, Supporting Information). In addi-
tion, MamA-mEGFP expression and mCherry binding to the 
magnetosome surface was confirmed by fluorescence micros-
copy (FM) (Figure 4D). Distinct signals were obtained at iden-
tical positions, thereby also confirming the successful display of 
RBP as an additional functionality. The latter might thus func-
tion as versatile “connector” for coupling reactions to any RFP-
tagged structures.
2.3. Generation of a Magnetosome-Based Multifunctional  
Magnetic Hydrogel Composite
To demonstrate the potential and versatility of our approach 
we used mCherry-RBP antigen-nanobody interactions to gen-
erate a multifunctional model composite material displaying 
magnetism as well as fluorescence and two different catalytic 
activities. For this purpose, we coupled magnetosomes isolated 
from strain ∆mamGFDC_∆mamA::mamA-megfp_mamG-gox_
mamF-gusA_mamC-rbp to commercial, highly porous, ceramic 
beads (50 µm in diameter; “Methyl Matrix–Ceramic HyperD 
F Hydrogel Composite”) (Figure 5A). The latter are filled with 
a derivatized hydrogel capable of protein binding and are 
commonly used in affinity chromatography.[43] When wildtype 
particles or magnetosomes expressing mEGFP, GOx, GusA, 
and RBP (Figure 5B) were mixed with the hydrogel beads in 
disposable polypropylene columns, a separation into two 
phases was observed with the magnetosomes being “repelled” 
and forming a distinct layer on top of the hydrogel matrix 
(Figure 5C). It can be assumed that the content of (functional-
ized) Mam proteins embedded in or attached to the magneto-
some surface is not sufficient to enable interactions with the 
hydrogel beads. Although our multifunctionalization approach 
Small 2020, 16, 1906922
Figure 5. Highly porous, ceramic beads filled with a derivatized hydrogel (A; “Methyl Matrix–Ceramic HyperD F Hydrogel Composite”) were incubated 
with MamA-mEGFP_MamG-GOx_MamF-GusA_MamC-RBP magnetosomes (B; TEM microscopy image, scale bar 100 nm). C) However, no homo-
genous suspension could be generated as the magnetosomes separated from the hydrogel beads forming a two-phase system and a layer on top of the 
matrix. D) Soluble mCherry protein was added to generate binding sites for MamA-mEGFP_MamG-GOx_MamF-GusA_MamC-RBP magnetosomes. 
Incorporation of the latter into the matrix by mCherry-RBP antigen-nanobody interactions led to a viscous, homogenous composite material that could 
be attracted by the pole of a permanent magnet. E) Microscopic analysis (DIC) was used to visualize the magnetosome incubated ceramic beads, exhib-
iting mEGFP fluorescence. F) Furthermore, the generated magnetosome-hydrogel composite material exhibited two different catalytic activities: GusA 
activity was indicated by formation of bluish 5,5′-dibromo-4,4′-dichloro-indigo in the presence of X-Gluc. G) After elution and multiple washing steps, 
GOx reaction buffer (supplemented with β-D-glucose) was applied to the column. GOx activity was visualized by formation of red formazan. H) The 
reusability of the magnetosome-hydrogel composite was shown by repeated removal and addition of substrate. For more details, please refer to the text.
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added up to 300 protein moieties in total to the surface of each 
magnetosome (according to the relative abundances of the 
different membrane anchors), still no incorporation into the 
matrix was observed. In order to enable specific interactions of 
MamA-mEGFP_MamG-GOx_MamF-GusA_MamC-RBP mag-
netosomes with the hydrogel beads, the latter were incubated 
with an access of soluble mCherry protein to generate RBP 
binding sites. Although only about 85 MamC-RBP fusion pro-
teins were displayed on the magnetosome surface (according to 
the relative abundance of MamC[23]), the mCherry-RBP antigen-
nanobody interaction seemed to be strong enough to “entrap” 
the magnetosomes in the matrix. Thus, mixing the hydrogel 
beads with MamA-mEGFP_MamG-GOx_MamF-GusA_MamC-
RBP magnetosomes led to a homogenous, viscous suspension, 
indicating mCherry recognition and binding of the RBP nano-
body (Figure 5D). By stable magnetosome incorporation into 
the hydrogel matrix, the entire composite material became mag-
netized, as demonstrated by attraction of the magnetosome-
hydrogel composite by a permanent magnet placed closely to 
the slurry. Microscopic analysis by differential interference 
contrast (DIC) and FM confirmed the presence of the fluores-
cent magnetosomes within the composite (Figure 5E). Next, 
after multiple steps of washing, substrates for the two different 
enzymatic activities were added successively: First, 1 mg X-Gluc 
(in 50 × 10−3 m 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid (Hepes)/NaOH, pH 7.2) was applied to and incubated in 
the column. X-Gluc hydrolysis was indicated by formation of 
a characteristic blue color of the supernatant and the magneto-
some-hydrogel suspension (Figure 5F). The 5,5′-dibromo-4,4′-
dichloro-indigo containing solution was finally eluted and the 
column was washed several times to remove residual substrate 
and reaction products prior to applying 5 mL GOx reaction 
buffer supplemented with β-D-glucose. The latter was subse-
quently turned into a red solution (Figure 5G), illustrating the 
reduction of 1-phenyl-2-(4-iodo-phenyl)-3-(4-nitrophenyl)-2H-
tetrazolium chloride (INT) to formazan. Repeated removal and 
addition of substrate led to reproducible, strong color genera-
tion over at least five cycles, indicating that the magnetosome-
hydrogel composite is recyclable (Figure 5H).
3. Conclusion
In this study, we explored the genetic multifunctionalization of 
the magnetosome surface by simultaneous utilization of dif-
ferent magnetosome membrane proteins. The abundances of 
the integral MamC, MamF, and MamG, and the membrane-
associated MamA proteins were estimated to be ≈85, ≈66, ≈60, 
and ≈85 copy numbers per particle, and we could demonstrate 
that the latter can serve as stable anchors for genetic fusions 
with more complex, e.g. multimeric cargo proteins and tandem 
fusions. The genetic expression of arrays of up to five copies 
of GusA fused to individual MamC anchors has been shown 
before, thereby triplicating enzymatic activities compared to 
single GusA expression.[23] Implementing this strategy simul-
taneously to our set of different, highly abundant anchor pro-
teins, this would greatly enhance the capacity to display foreign 
cargo proteins. Simultaneously functionalized, the membrane 
proteins MamC, MamF, MamG, and MamA would provide up 
to 300 sites for covalent and highly specific attachment. Thus, 
the expression of arrays of up to five copies of a foreign moiety 
could lead to multifunctional magnetosomes with theoretically 
up to 1500 functional cargo proteins in total displayed on the 
particle surface.
Numerous in vitro strategies to generate functionalized 
nanoparticles are based on well-known surface chemistries 
and chemical coupling reactions,[15,16] however, heterogeneity 
and precise control over the stoichiometric number of func-
tional moieties on the surface are still challenging issues.[44] 
Although chemical approaches allow for high coupling 
levels,[45–47] they lack specificity and are often accompanied 
by denaturing effects, which might lead to a loss of biological 
activity. In contrast, the in vivo functionalization of the mag-
netosome membrane by genetic engineering provides unprece-
dented selectivity and precise control over coupling of multiple 
protein cargos with variable stoichiometry.
The different proteins displayed on the surface of our engi-
neered model particles could be easily substituted by any 
other desirable, non-toxic cargo moieties with biomedical or 
biotechnological relevance. For instance, the use of immobi-
lized enzymes (on hydrogels or microbeads) in biocatalytic 
flow-reactor concepts was investigated, revealing the need for 
appropriate methods for the immobilization of enzymes.[48,49] 
Likewise, magnetosomes might serve as a versatile scaffold for 
the spatial organization of different catalytic activities, thereby 
enabling cascade reactions through the close proximity of the 
constituting enzyme species and balanced substrate channeling 
rates.[50] The feasibility to use functionalized magnetosomes as 
reusable, multimodal catalysts could be demonstrated in this 
study by incorporating MamA-mEGFP_MamG-GOx_MamF-
GusA_MamC-RBP magnetosomes into mCherry-equipped 
hydrogel-based matrices (Figure 5), which resulted in a model 
magnetic composite material with different catalytic activities. 
In addition, the introduction of molecular connectors ren-
ders magnetosomes a versatile platform that allows coupling 
of any cognate epitope-tagged or cellular structure. Mickoleit 
et al., for instance, expressed streptavidin or green fluorescent 
binding protein (GBP) nanobodies on the particle surface.[51] 
The resulting magnetosomes were capable of binding biotin- 
or GFP-tagged particles of the tobacco mosaic virus, thereby 
generating a new kind of biocomposite that could serve as 
magnetic scaffold for adding further functionalities. Moreover, 
magnetosome expression/coupling of cell signaling ligands 
might facilitate and stabilize their oligomerization as it was 
shown for CD40 ligands,[52] thereby triggering signaling cas-
cades by specific interactions with the corresponding receptors 
and enabling the in vitro production of therapeutic, polyclonal 
antibody formulations.[53]
In summary, our synthetic biology approach provides an 
elegant, powerful and highly selective route for the generation 
of engineered nanoparticles, in which all of the multiple func-
tionalities (i.e., the presence of a core-shell structure, strong 
magnetization, fluorescence, several catalytic activities and ver-
satile coupling groups) are fully genetically encoded. Therefore, 
engineered magnetosomes are highly promising as building 
blocks for more complex nano- and mesostructures with 
enhanced properties for many biotechnological and biomedical 
applications.
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4. Experimental Section
Bacterial Strains, Plasmids, and Cultivation Conditions: Bacterial 
strains and plasmids that were used in this study are listed in Tables S4 
and S5 (Supporting Information). M. gryphiswaldense strains were 
grown microaerobically in modified flask standard medium (FSM) at 
30 °C according to Heyen and Schüler.[54] E. coli strains were grown as 
previously described.[55] For the cultivation of E. coli WM3064 (W. Metcalf, 
unpublished), d,l-α,ε-diaminopimelic acid (DAP) was added to lysogeny 
broth (LB) medium at a final concentration of 1 × 10−3 m. Strains were 
routinely cultured as described previously.[18,23] For the cultivation 
on solid medium 1.5% (w/v) agar was added, for strains carrying 
recombinant plasmids, media were supplemented with 25 µg mL−1 
kanamycin (Km) for E. coli or 5 µg mL−1 for M. gryphiswaldense strains.
Molecular and Genetic Techniques: Oligonucleotides (see 
Table S6, Supporting Information) were purchased from Sigma-
Aldrich (Steinheim, Germany). Plasmids were constructed by standard 
recombinant techniques as described in detail below.
For the construction of M. gryphiswaldense strains carrying gusA-megfp 
fusions (strains MSR-1 FM1 to FM6), the insertion plasmid pFM2 (which 
harbors a mamC-gusA-megfp expression cassette[23]) was subjected to 
double enzymatic digestion with NdeI and NcoI. mamF, mamG and mamA 
were amplified from isolated genomic DNA of M. gryphiswaldense MSR-1 
R3/S1 using primer pairs mamF NdeI fwd/mamF NcoI rev, mamG NdeI 
fwd/mamG NdeI rev or mamA NdeI fwd/mamA NcoI rev, respectively. 
PCR products were cloned at the corresponding sites into the NdeI/NcoI 
restriction sites of the previously digested expression cassette of pFM2, 
thereby generating pFM3, pFM4, or pFM5. The latter were transferred 
either to the wildtype of M. gryphiswaldense (thereby generating strains 
M. gryphiswaldense MSR-1 FM1-3) or the corresponding isogenic deletion 
strains M. gryphiswaldense ∆mamF, ∆mamG, or ∆mamA (which resulted 
in strains M. gryphiswaldense MSR-1 FM4-6, respectively). mam-gusA-megfp 
expression cassettes were chromosomally inserted by Tn5 transposition at 
random positions, allowing stable expression of the fusion proteins.
For generating magnetosomes that display several functional moieties 
on the surface, different Mam proteins were simultaneously utilized as 
membrane anchors. A chromosomal mamA-megfp fusion (in-frame 
replacement of the native mamA) was generated by a markerless 
mutagenesis approach as previously described.[35] A fragment consisting 
of the mamA-megfp sequence flanked by the upstream and downstream 
regions of mamA (≈1 kb each) was constructed in a Gibson Assembly 
reaction (Table S7, Supporting Information).[56] Primers EcoRI H1-mamA 
fwd and Gibson mamA rev were used to amplify a sequence consisting 
of mamA and its upstream region, thereby generating a EcoRI restriction 
site at the 5′ end and a 45 bp overhang downstream of mamA. megfp 
was amplified from pJH1 applying primers Gibson egfp fwd and Gibson 
egfp rev, and primers Gibson H2 fwd and H2 BamHI rev were used 
to amplify the downstream region of mamA from genomic DNA. In 
all reactions, sequences with complementary, overlapping ends were 
generated. The fragments were simultaneously ligated and cloned at the 
EcoRI/BamHI restriction sites into the previously digested pFM271e_1 
using Gibson Assembly reaction, thereby generating pFM271e_mamA-
megfp. In addition, the ampicillin resistance cassette (amp) was 
amplified from pSB9 (primers Amp NheI fwd and Amp SpeI rev) and 
cloned into NheI/SpeI restrictions sites of pFM271e_mamA-megfp. The 
resulting plasmid (pFM271e_mamA-megfp_amp) was transferred to the 
wildtype and ∆mamGFDC strain of M. gryphiswaldense.
For the construction of a mamG-gox_mamF-gusA_mamG-rbp 
expression cassette under control of the optimized PmamDC45 promotor, 
three different gene fusions were designed and ligated in a Gibson 
Assembly reaction,[56] Figure S4 (Supporting Information). A sequence 
consisting of a gly10 linker and codon-optimized, monomeric glucose 
oxidase (gly10-gox) was synthesized by ATG:biosynthetics (Merzhausen, 
Germany), with NdeI or BamHI restriction sites flanking the 5′ or 3′ 
terminus, respectively. gly10-gox was amplified using primers GOx fwd 
and GOx rev and ligated into NcoI and BamHI restriction sites of pFM4 
resulting in pFM1. Primers Gibson mamG fwd and mamG-gox rev were 
subsequently used to amplify the mamG-gox fragment, with an NdeI 
restriction site upstream of mamG. mamF-gusA was amplified from 
pFM3 applying primers Gibson mamF fwd and Gibson mamF-gusA rev, 
and mamC-rbp was amplified from pAP179[19] using primers Gibson 
mamC fwd and rbp rev, resulting in a fragment with a BamHI restriction 
site downstream of rbp. In all reactions, sequences with complementary, 
overlapping ends were generated (corresponding to the intergenic 
regions of the mamGFDC operon). The fragments were simultaneously 
ligated to a mamG-gox_mamF-gusA_mamC-rbp fusion and cloned at the 
NdeI/BamHI restriction sites into the previously digested pSB9 using 
Gibson Assembly reaction (Table S7, Supporting Information).
All constructs were sequenced by Macrogen Europe (Amsterdam, 
Netherlands) using the cutting edge technology. Sequence data were 
analyzed with Geneious 8.0.5 (Biomatters Ltd.) and ApE 2.0.47 (M. 
Wayne Davis, 2009).
Spectrophotometric Measurement of Glucuronidase Activity: The 
glucuronidase GusA (EC 3.2.1.31) is an acid hydrolase with a molecular 
weight of 68.3 kDa. It catalyzes the cleavage of 3-glucuronides, yielding 
3-glucuronates and an alcohol. The enzyme is easily and sensitively 
assayed using commercially available glucuronide substrates.[57]
For kinetic studies on the GusA activity of isolated magnetosomes, 
a modified protocol from Myronovskyi et al. was used.[58] 1.0 mL 
(0.1–0.3 µg Fe) of purified particles in dilution buffer (5 × 10−3 m DTT, 
0.1% Triton X-100, pH 7.0) were centrifuged and incubated at 37 °C 
for 15 min. Finally, 5–100 µL 0.2 m p-nitrophenyl-β-D-glucuronide were 
added to the magnetosome pellet to start the time-dependent reaction 
(carried out at 37 °C). The production of p-nitrophenol was monitored 
by measuring the optical density at 415 nm (OD415). As reference, 
1.0 mL dilution buffer without magnetosomes was used. Units were 
micromoles (µmol) of product formed per minute at 37 °C. Reported 
values were averaged from at least three independent cultures.
For qualitative determination/assessment of the GusA activity, 
the commercial substrate X-Gluc (5-bromo-4-chloro-3-indolyl-β-D-
glucuronic acid, cyclohexylammonium salt) was used. 100 µL cell 
suspension of isolated magnetosomes were supplemented with 100 µg 
X-Gluc (10 µL of a 10 mg mL−1 stock solution). X-Gluc was hydrolyzed 
by magnetosome-bound GusA yielding glucuronic acid and 5-bromo-4- 
chloro-indoxyl. The latter was subsequently oxidized to 5,5′-dibromo-
4,4′-dichloro-indigo, resulting in a characteristic blue color.
GOx Activity Assay: For measuring glucose oxidizing activity of GOx 
displaying magnetosomes, an assay which had previously been used 
to quantify enzyme-based electron transfer reactions was modified.[40] 
250 µL β-D-glucose solution (0.5 m) was added to 1 mL oxygen-saturated 
reaction buffer (123.75 × 10−6 m INT, 22.25 × 10−6 m 1-methoxyphenazine 
5-methosulfate (MPMS), 0.625 (w/v) Triton X-100 in 50 × 10−3 m 
KH2PO4/NaOH pH 7.2) and incubated at 35 °C for 5 min. The reaction 
was started by adding 50 µL magnetosome suspension (with a defined 
Fe content), and the time-dependent absorption increase A496nm was 
monitored for at least 35 min (Evolution 201 UV-Vis spectrophotometer; 
Thermo Scientific Instruments, Madison, Wisconsin, USA). A solution 
of commercial glucose oxidase (0.08 U mL–1) served as positive control. 
In the assay, electrons released in the course of glucose oxidation were 
transferred to the intermediate electron “carrier” MPMS. The latter finally 
reduced INT yielding formazan, whose formation could be monitored at 
496 nm (Figure S7, Supporting Information).
Determination of FAD: To investigate whether FAD became inserted 
and remained bound to the magnetosome-associated GOx monomers 
in vivo, the magnetosome membrane fraction was solubilized and 
the protein compounds denatured and precipitated, thereby releasing 
enzyme-bound cofactors. FAD was determined in supernatants 
neutralized with 2.4 × 10−3 m K2HPO4 from its absorption at 450 nm 
in the oxidized and reduced state, employing the molar differential 
extinction coefficient ε450 of FAD.[59,60]
Determination of Iron Concentrations: Iron contents of cells and 
isolated magnetosomes were determined by flame atomic absorption 
spectroscopy. For that purpose, appropriate (e.g., 1:10–1:100) dilutions 
of the corresponding fractions were prepared. Magnetosomes or cells 
(suspensions of equal optical density) were pelleted, resuspended in 
0.5 mL 69% nitric acid and digested at 98 °C for 3 h. The measurements 
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were conducted with a Perkin-Elmer Atomic Absorption Spectrometer 
1100 B (Überlingen, Germany) using the following conditions: 
wavelength 248.3 nm, gap width 0.2 nm, lamp current 20 mA.
Analytical Methods: Optical density (OD) and magnetic response 
(Cmag) of late exponentially phase cells were measured photometrically 
at 565 nm as previously reported.[61] Magnetosome expression of 
mEGFP or mCherry-binding to RBP was assayed by fluorescence 
microscopy (Olympus IX81 microscope equipped with a Hamamatsu 
Orca AG camera) as described before.[17] Briefly, to verify the expression 
of RBP nanobodies on the magnetosome surface, purified MamA-
mEGFP_MamG-GOx_MamF-GusA_MamC-RBP magnetosomes were 
incubated with commercial, soluble mCherry. After removal of unbound 
fluorophore by magnetic separation and multiple washing steps, 
mCherry-loaded particles were analyzed by fluorescence microscopy. 
Image rescaling and cropping were performed with Corel Photopaint 
12.0 and GIMP (GNU Image Manipulation Program) 2.8.10 software.
For TEM of whole cells and isolated magnetosomes, specimens were 
directly deposited onto carbon-coated copper grids (Science Services, 
Munich, Germany). Magnetosomes were stained with 1% uranyl 
acetate. Transmission electron microscopy was performed on a CEM 
902A (Zeiss, Oberkochen, Germany) with an acceleration voltage of 
80 kV. Images were taken with a Gata Erlangshen ES500W CCD camera. 
Sizes of crystals were measured with ImageJ software.
Biochemical Methods: Isolation of bacterial magnetosomes from 
M. gryphiswaldense was performed as previously described.[17,54] 
Denaturing polyacrylamide gels were prepared according to the method 
of Laemmli,[62] modified after Fling and Gregerson.[63] Magnetosome 
membrane protein fractions solubilized from isolated particles 
(0.5–10 µg Fe) were separated by electrophoresis and subsequently 
transferred onto polyvinylidene difluoride (PVDF) membranes (Roth, 
Germany). Immunochemical detection of Mam-GusA fusion proteins 
was performed as previously described,[23] using a rabbit anti-GusA IgG 
primary antibody (Antibodies-Online, Aachen, Germany) at a 1:7500 
ratio. IgG antibodies specific for GFP (Santa Cruz Biotechnology, 
Heidelberg, Germany) were applied to detect MamA-mEGFP in the 
magnetosome membrane fraction (ratio 1:3000).
Incorporation of Magnetosomes into Hydrogel-based Matrices: 
Magnetosome–hydrogel bead composites were generated by incubating 
1.5 mL “Methyl Matrix: Ceramic HyperD F Hydrogel Composite” 
(provided as aqueous ethanol suspension, 50 µm mean particle 
size; Sigma-Aldrich, Steinheim, Germany) with soluble mCherry 
protein (TP790040; OriGene, Herford, Germany). The composite was 
subsequently filled into disposable polypropylene columns (Thermo 
Fisher Scientific, Dreieich, Germany) prior to adding/resuspending the 
indicated magnetosome suspensions.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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